<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39460261</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Scoping Review of Factors Affecting COVID-19 Vaccination Uptake and Deployment in Global Healthcare Systems.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1093</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12101093</ELocationID><Abstract><AbstractText><b>Introduction</b>: COVID-19 vaccines were rapidly developed and deployed on a large scale during a global crisis. A range of deployment strategies were used globally to maximize vaccine uptake. In this scoping review, we identify and analyze the main healthcare system and policy factors that guided and influenced COVID-19 vaccination deployment and uptake globally. <b>Materials and Methods</b>: JBI guidelines, Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR), and the population, concept, and context (PCC) framework were applied. Studies on individual COVID-19 vaccination factors, such as vaccine hesitancy, were excluded. The search was last conducted in May 2024 yielding 26,686 articles from PubMed, Embase, CINAHL, Scopus, and COVID-19 websites. A total of 47 articles and 3 guidance documents were included. The results of the thematic analysis were mapped to the Consolidated Framework for Implementation Research (CFIR). <b>Results</b>: The results found the following healthcare system and policy factors as integral to COVID-19 vaccination: types of vaccine products, healthcare workforce capacity, procurement strategies, distribution and cold-chain capacity, partnership, coordination, and leadership, information, communication, and registration strategies, delivery models, organizations, the existing health systems and policies on prioritization of at-risk groups and deployment plans. <b>Discussion</b>: Globally, COVID-19 vaccination programs responded to the pandemic by leveraging and reforming the existing healthcare systems, relying on strong leadership and global cooperation (such as the COVID-19 Vaccines Global Access Initiative). Deployment was enabled by effective communication and adoption of innovative technologies using data-driven policies to create high vaccine demand while overcoming limited vaccine supply and rapidly adapting to uncertainties.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kandulu</LastName><ForeName>Chikondi C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-8595-7543</Identifier><AffiliationInfo><Affiliation>Pharmaceutical Care Research Group, University College Cork, College Rd, T12 K8AF Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahm</LastName><ForeName>Laura J</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0000-0002-7496-9477</Identifier><AffiliationInfo><Affiliation>Pharmaceutical Care Research Group, University College Cork, College Rd, T12 K8AF Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mercy University Hospital, Grenville Place, T12 WE28 Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saab</LastName><ForeName>Mohamad M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-7277-6268</Identifier><AffiliationInfo><Affiliation>Catherine McAuley School of Nursing and Midwifery, University College Cork, Brookfield Health Sciences Complex, T12 AK54 Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Driscoll</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Research Group, University College Cork, College Rd, T12 K8AF Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Catherine McAuley School of Nursing and Midwifery, University College Cork, Brookfield Health Sciences Complex, T12 AK54 Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorter</LastName><ForeName>Gillian W</ForeName><Initials>GW</Initials><Identifier Source="ORCID">0000-0001-5752-2297</Identifier><AffiliationInfo><Affiliation>School of Psychology, Queen's University Belfast, Belfast BT9 5BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Psychology, Queen's University Belfast, Belfast BT9 5BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Anne C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0003-3656-4230</Identifier><AffiliationInfo><Affiliation>School of Biochemistry and Cell Biology, University College Cork, T12 XF62 Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Bioprocessing Research and Training, A94 X099 Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleming</LastName><ForeName>Aoife</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5330-951X</Identifier><AffiliationInfo><Affiliation>Pharmaceutical Care Research Group, University College Cork, College Rd, T12 K8AF Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mercy University Hospital, Grenville Place, T12 WE28 Cork, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NA</GrantID><Agency>All-island Vaccine Research and Training Alliance (AIVRT) and the Higher Education Authority (HEA) North-South Research Programme</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">health policy</Keyword><Keyword MajorTopicYN="N">healthcare systems</Keyword><Keyword MajorTopicYN="N">immunization programs</Keyword><Keyword MajorTopicYN="N">vaccination strategies</Keyword><Keyword MajorTopicYN="N">vaccine access</Keyword><Keyword MajorTopicYN="N">vaccine campaign</Keyword><Keyword MajorTopicYN="N">vaccine deployment</Keyword><Keyword MajorTopicYN="N">vaccine implementation</Keyword><Keyword MajorTopicYN="N">vaccine rollout</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39460261</ArticleId><ArticleId IdType="pmc">PMC11511325</ArticleId><ArticleId IdType="doi">10.3390/vaccines12101093</ArticleId><ArticleId IdType="pii">vaccines12101093</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Utami A.M., Rendrayani F., Khoiry Q.A., Noviyanti D., Suwantika A.A., Postma M.J., Zakiyah N. Economic evaluation of COVID-19 vaccination: A systematic review. J. Glob. Health. 2023;13:06001. doi: 10.7189/jogh.13.06001.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.06001</ArticleId><ArticleId IdType="pmc">PMC9838689</ArticleId><ArticleId IdType="pubmed">36637810</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas E.J., McLaughlin J.M., Khan F., Angulo F.J., Anis E., Lipsitch M., Singer S.R., Mircus G., Brooks N., Smaja M., et al. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: A retrospective surveillance study. Lancet Infect. Dis. 2022;22:357–366. doi: 10.1016/S1473-3099(21)00566-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00566-1</ArticleId><ArticleId IdType="pmc">PMC8457761</ArticleId><ArticleId IdType="pubmed">34562375</ArticleId></ArticleIdList></Reference><Reference><Citation>Regan J.J. Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices—United States, September 2023. MMWR Morb. Mortal. Wkly. Rep. 2023;72:1140–1146. doi: 10.15585/mmwr.mm7242e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7242e1</ArticleId><ArticleId IdType="pmc">PMC10602621</ArticleId><ArticleId IdType="pubmed">37856366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashte S., Gulbake A., El-Amin S.F., III, Gupta A. COVID-19 vaccines: Rapid development, implications, challenges and future prospects. Hum. Cell. 2021;34:711–733. doi: 10.1007/s13577-021-00512-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13577-021-00512-4</ArticleId><ArticleId IdType="pmc">PMC7937046</ArticleId><ArticleId IdType="pubmed">33677814</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavi and Global Health Actors Collaborate to Accelerate COVID-19 Technologies for All. 2022.  [(accessed on 22 June 2024)].  Available online:  https://www.gavi.org/news/media-room/gavi-and-global-health-actors-collaborate-accelerate-covid-19-technologies-all.</Citation></Reference><Reference><Citation>COVAX Explained.  [(accessed on 3 April 2024)].  Available online:  https://www.gavi.org/vaccineswork/covax-explained.</Citation></Reference><Reference><Citation>COVAX Facility Governance Explained.  [(accessed on 19 August 2022)].  Available online:  https://www.gavi.org/vaccineswork/covax-facility-governance-explained.</Citation></Reference><Reference><Citation>Guidance on Developing a National Deployment and Vaccination Plan for COVID-19 Vaccines.  [(accessed on 2 July 2024)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine-deployment-2021.1-eng.</Citation></Reference><Reference><Citation>Naik S., Paleja A., Mahajan M., Ramachandran N., Dixit S., Matthan R., Pai N., Kotasthane P. A COVID-19 Vaccine Deployment Strategy for India. Indian Public Policy Rev. 2020;1:42–58. doi: 10.55763/ippr.2020.01.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.55763/ippr.2020.01.02.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacocke E.F., Heupink L.F., Frønsdal K., Dahl E.H., Chola L. Global access to COVID-19 vaccines: A scoping review of factors that may influence equitable access for low and middle-income countries. BMJ Open. 2021;11:e049505. doi: 10.1136/bmjopen-2021-049505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-049505</ArticleId><ArticleId IdType="pmc">PMC8487019</ArticleId><ArticleId IdType="pubmed">34593496</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer K., Nemer L., Datta S.S., Menne B.M. COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned. Front. Public Health. 2022;10:959227. doi: 10.3389/fpubh.2022.959227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.959227</ArticleId><ArticleId IdType="pmc">PMC9541336</ArticleId><ArticleId IdType="pubmed">36211689</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO SAGE Roadmap for Prioritizing Uses of COVID-19 Vaccines: An Approach to Optimize the Global Impact of COVID-19 Vaccines, Based on Public Health Goals, Global and National Equity, and Vaccine Access and Coverage Scenarios.  [(accessed on 18 July 2024)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2023.1.</Citation></Reference><Reference><Citation>Wang W.-C., Fann J.C.-Y., Chang R.-E., Jeng Y.-C., Hsu C.-Y., Chen H.-H., Liu J.-T., Yen A.M.-F. Economic evaluation for mass vaccination against COVID-19. J. Formos. Med. Assoc. 2021;120:S95–S105. doi: 10.1016/j.jfma.2021.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2021.05.020</ArticleId><ArticleId IdType="pmc">PMC8148613</ArticleId><ArticleId IdType="pubmed">34108119</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim F. Early COVID-19 vaccination rollout: A commentary from England. Isr. J. Health Policy Res. 2021;10:18. doi: 10.1186/s13584-021-00451-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13584-021-00451-3</ArticleId><ArticleId IdType="pmc">PMC7907783</ArticleId><ArticleId IdType="pubmed">33637133</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutledge P.E. Trump, COVID-19, and the War on Expertise. Am. Rev. Public Adm. 2020;50:505–511. doi: 10.1177/0275074020941683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0275074020941683</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochhar S., Edwards K.M., Ropero Alvarez A.M., Moro P.L., Ortiz J.R. Introduction of new vaccines for immunization in pregnancy—Programmatic, regulatory, safety and ethical considerations. Vaccine. 2019;37:3267–3277. doi: 10.1016/j.vaccine.2019.04.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.04.075</ArticleId><ArticleId IdType="pmc">PMC6771279</ArticleId><ArticleId IdType="pubmed">31072733</ArticleId></ArticleIdList></Reference><Reference><Citation>Chughtai A.A., Mohammed S., Al Ariqi L., McCarron M., Bresee J., Abubakar A., Khan W. Development of a road map to scale up the uptake and utilization of influenza vaccine in 22 countries of Eastern Mediterranean Region. Vaccine. 2022;40:6558–6565. doi: 10.1016/j.vaccine.2022.09.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.09.051</ArticleId><ArticleId IdType="pubmed">36208976</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt A., Monk V., Bhatti A., Eiden A.L., Hermany L., Hansen N., Connolly M.P., Baxter L., Vanderslott S., Mitrovich R., et al. Identifying factors that can be used to assess a country’s readiness to deploy a new vaccine or improve uptake of an underutilised vaccine: A scoping review. BMJ Open. 2024;14:e080370. doi: 10.1136/bmjopen-2023-080370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-080370</ArticleId><ArticleId IdType="pmc">PMC11086410</ArticleId><ArticleId IdType="pubmed">38719292</ArticleId></ArticleIdList></Reference><Reference><Citation>Van De Pas R., Widdowson M.-A., Ravinetto R., Srinivas P.N., Ochoa T.J., Fofana T.O., Van Damme W. COVID-19 vaccine equity: A health systems and policy perspective. Expert Rev. Vaccines. 2022;21:25–36. doi: 10.1080/14760584.2022.2004125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2022.2004125</ArticleId><ArticleId IdType="pmc">PMC8631691</ArticleId><ArticleId IdType="pubmed">34758678</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal M., Kokorelias K.M., Glazier R.H., Katz A., Shiers-Hanley J.E., Upshur R.E.G. What is the role of primary care in the COVID-19 vaccine roll-out and the barriers and facilitators to an equitable vaccine roll-out? A rapid scoping review of nine jurisdictions. BMJ Open. 2023;13:e065306. doi: 10.1136/bmjopen-2022-065306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-065306</ArticleId><ArticleId IdType="pmc">PMC10123853</ArticleId><ArticleId IdType="pubmed">37076148</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters M.D.J., Marnie C., Tricco A.C., Pollock D., Munn Z., Alexander L., McInerney P., Godfrey C.M., Khalil H. Updated methodological guidance for the conduct of scoping reviews. JBI Evid. Implement. 2021;19:3. doi: 10.1097/XEB.0000000000000277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/XEB.0000000000000277</ArticleId><ArticleId IdType="pubmed">33570328</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco A.C., Lillie E., Zarin W., O’Brien K.K., Colquhoun H., Levac D., Moher D., Peters M.D.J., Horsley T., Weeks L., et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann. Intern. Med. 2018;169:467–473. doi: 10.7326/M18-0850.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-0850</ArticleId><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>McGowan J., Sampson M., Salzwedel D.M., Cogo E., Foerster V., Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J. Clin. Epidemiol. 2016;75:40–46. doi: 10.1016/j.jclinepi.2016.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2016.01.021</ArticleId><ArticleId IdType="pubmed">27005575</ArticleId></ArticleIdList></Reference><Reference><Citation>Damschroder L.J., Reardon C.M., Widerquist M.A.O., Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement. Sci. 2022;17:75. doi: 10.1186/s13012-022-01245-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-022-01245-0</ArticleId><ArticleId IdType="pmc">PMC9617234</ArticleId><ArticleId IdType="pubmed">36309746</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Shi L., Chen H., Wang X., Jiao J., Liu M., Yang J., Sun G. Comparison of COVID-19 Vaccine Policies in Italy, India, and South Africa. Vaccines. 2022;10:1554. doi: 10.3390/vaccines10091554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10091554</ArticleId><ArticleId IdType="pmc">PMC9505201</ArticleId><ArticleId IdType="pubmed">36146632</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati K., Busari J. Vaccinating a billion people against COVID-19: India’s quest for systems leadership in exceptional times. Leadersh. Health Serv. 2021;35:137–148. doi: 10.1108/LHS-05-2021-0045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/LHS-05-2021-0045</ArticleId><ArticleId IdType="pubmed">34787981</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur D. India’s COVID-19 vaccination policy-an analysis of problem, politics and policy. Int. J. Health Gov. 2022;27:217–228. doi: 10.1108/IJHG-10-2021-0107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/IJHG-10-2021-0107</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayasinghe S., Patel C., Armstrong L., Chiu C., Macartney K., Flanagan K., Gibney K., Giles M., Crawford N., Cheng A., et al. ATAGI Targeted Review 2021: The national COVID-19 vaccination program. Commun. Dis. Intell. 2023;47:1–23. doi: 10.33321/cdi.2023.47.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.33321/cdi.2023.47.20</ArticleId><ArticleId IdType="pubmed">37106451</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo C., Villalobos Dintrans P., Maddaleno M. The successful COVID-19 vaccine rollout in Chile: Factors and challenges. Vaccine X. 2021;9:100114. doi: 10.1016/j.jvacx.2021.100114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2021.100114</ArticleId><ArticleId IdType="pmc">PMC8425670</ArticleId><ArticleId IdType="pubmed">34518818</ArticleId></ArticleIdList></Reference><Reference><Citation>da Fonseca E.M., Shadlen K.C., Bastos F.I. The politics of COVID-19 vaccination in middle-income countries: Lessons from Brazil. Soc. Sci. Med. 2021;281:114093. doi: 10.1016/j.socscimed.2021.114093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2021.114093</ArticleId><ArticleId IdType="pmc">PMC9188662</ArticleId><ArticleId IdType="pubmed">34144480</ArticleId></ArticleIdList></Reference><Reference><Citation>AlShurman B.A., Tetui M., Nanyonjo A., Butt Z.A., Waite N.M., Vernon-Wilson E., Wong G., Grindrod K. Understanding the COVID-19 Vaccine Policy Terrain in Ontario Canada: A Policy Analysis of the Actors, Content, Processes, and Context. Vaccines. 2023;11:782. doi: 10.3390/vaccines11040782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11040782</ArticleId><ArticleId IdType="pmc">PMC10143674</ArticleId><ArticleId IdType="pubmed">37112694</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini M., Eid M.A., Falkenbach M., Rosenbluth S.T., Prieto P.A., Brammli-Greenberg S., McMeekin P., Paolucci F. An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes. Health Policy Technol. 2022;11:100594. doi: 10.1016/j.hlpt.2021.100594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2021.100594</ArticleId><ArticleId IdType="pmc">PMC8702636</ArticleId><ArticleId IdType="pubmed">34976711</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss E., Patterson N.A., Seals B.F. An Examination of US COVID-19 Vaccine Distribution in New Jersey, Pennsylvania, and New York. Int. J. Environ. Res. Public Health. 2022;19:15629. doi: 10.3390/ijerph192315629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192315629</ArticleId><ArticleId IdType="pmc">PMC9738558</ArticleId><ArticleId IdType="pubmed">36497703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiirinki H., Viita-aho M., Tynkkynen L.-K., Sovala M., Jormanainen V., Keskimäki I. COVID-19 in Finland: Vaccination strategy as part of the wider governing of the pandemic. Health Policy Technol. 2022;11:100631. doi: 10.1016/j.hlpt.2022.100631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2022.100631</ArticleId><ArticleId IdType="pmc">PMC9008981</ArticleId><ArticleId IdType="pubmed">35437478</ArticleId></ArticleIdList></Reference><Reference><Citation>Phuntsho S., Tshokey T., Gurung M.S., Wangdi S., Wangdi S., Wangchuk S. An Exemplary National COVID-19 Vaccination: Lessons from Bhutan. Trop. Med. Infect. Dis. 2022;7:131. doi: 10.3390/tropicalmed7070131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed7070131</ArticleId><ArticleId IdType="pmc">PMC9322184</ArticleId><ArticleId IdType="pubmed">35878143</ArticleId></ArticleIdList></Reference><Reference><Citation>Purohit N., Chugh Y., Bahuguna P., Prinja S. COVID-19 management: The vaccination drive in India. Health Policy Technol. 2022;11:100636. doi: 10.1016/j.hlpt.2022.100636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2022.100636</ArticleId><ArticleId IdType="pmc">PMC9069978</ArticleId><ArticleId IdType="pubmed">35531441</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen B., Waitzberg R., Israeli A. Israel’s rapid rollout of vaccinations for COVID-19. Isr. J. Health Policy Res. 2021;10:6. doi: 10.1186/s13584-021-00440-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13584-021-00440-6</ArticleId><ArticleId IdType="pmc">PMC7835664</ArticleId><ArticleId IdType="pubmed">33499905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kholina K., Harmon S.H.E., Graham J.E. An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada. PLoS ONE. 2022;17:e0279929. doi: 10.1371/journal.pone.0279929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0279929</ArticleId><ArticleId IdType="pmc">PMC9803301</ArticleId><ArticleId IdType="pubmed">36584230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloomstone S., Fleming M., Arana M., D’Angelo E., Ravenhall S., Murrman M. COVID-19 Vaccine Administration: Phase 2 of an in Progress Review in New York State Local Health Departments. Int. J. Environ. Res. Public Health. 2022;19:13030. doi: 10.3390/ijerph192013030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192013030</ArticleId><ArticleId IdType="pmc">PMC9603115</ArticleId><ArticleId IdType="pubmed">36293615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S.A. Six Pivotal Lessons Learned in South Korea for Whole-of-Government Approach to Successful COVID-19 Vaccine Rollout in Planetary Health. OMICS J. Integr. Biol. 2022;26:567–579. doi: 10.1089/omi.2022.0064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2022.0064</ArticleId><ArticleId IdType="pubmed">36112347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon S.L., Oh J. COVID-19 vaccination program in South Korea: A long journey toward a new normal. Health Policy Technol. 2022;11:100601. doi: 10.1016/j.hlpt.2022.100601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2022.100601</ArticleId><ArticleId IdType="pmc">PMC8801590</ArticleId><ArticleId IdType="pubmed">35127400</ArticleId></ArticleIdList></Reference><Reference><Citation>Pammal R.S., Kreinces J.B., Pohlman K.L. Importance of Pharmacy Partnerships in Effective COVID-19 Vaccine Distribution. Disaster Med. Public Health Prep. 2022;16:2293–2295. doi: 10.1017/dmp.2021.178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/dmp.2021.178</ArticleId><ArticleId IdType="pmc">PMC8314053</ArticleId><ArticleId IdType="pubmed">34099082</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggar C., Santoli J.M., Noblit C., Moore L.B., El Kalach R., Bridges C.B. U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020–May 2023. Vaccine. 2024 doi: 10.1016/j.vaccine.2024.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2024.02.020</ArticleId><ArticleId IdType="pmc">PMC11366301</ArticleId><ArticleId IdType="pubmed">38360476</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiirinki H., Sovala M., Jormanainen V., Goebeler S., Parhiala K., Tynkkynen L.-K., Keskimäki I. COVID-19 endemic phase in Finland: An analysis of health policies and vaccination strategy. Health Policy Technol. 2024;13:100800. doi: 10.1016/j.hlpt.2023.100800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2023.100800</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen A.K., Sobczyk E.A., Coyle R., Tirmal A., Hannan C. How ready was the US vaccination infrastructure and network of immunization information systems for COVID-19 vaccination campaigns: Recommendations to strengthen the routine vaccination program and prepare for the next pandemic. Hum. Vaccines Immunother. 2022;18:2088010. doi: 10.1080/21645515.2022.2088010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2088010</ArticleId><ArticleId IdType="pmc">PMC9621060</ArticleId><ArticleId IdType="pubmed">35796624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie J.A., Buchanan J., Schneider C.H., Paolucci F. COVID 19 Vaccines and the Australian health care state. Health Policy Technol. 2022;11:100607. doi: 10.1016/j.hlpt.2022.100607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2022.100607</ArticleId><ArticleId IdType="pmc">PMC8842088</ArticleId><ArticleId IdType="pubmed">35190790</ArticleId></ArticleIdList></Reference><Reference><Citation>Desson Z., Kauer L., Otten T., Peters J.W., Paolucci F. Finding the way forward: COVID-19 vaccination progress in Germany, Austria and Switzerland. Health Policy Technol. 2022;11:100584. doi: 10.1016/j.hlpt.2021.100584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2021.100584</ArticleId><ArticleId IdType="pmc">PMC8627596</ArticleId><ArticleId IdType="pubmed">34868834</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham S.A.A., Amoah J.O., Agyare D.F., Sekimpi D.K., Bosomtwe-Duker D., Druye A.A., Osei Berchie G., Obiri-Yeboah D. Health service factors affecting the COVID-19 vaccination campaign in a Ghanaian metropolis: A qualitative exploratory study. BMJ Open. 2023;13:e076184. doi: 10.1136/bmjopen-2023-076184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-076184</ArticleId><ArticleId IdType="pmc">PMC10749017</ArticleId><ArticleId IdType="pubmed">38128932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma M., Shi L., Liu M., Yang J., Xie W., Sun G. Comparison of COVID-19 vaccine policies and their effectiveness in Korea, Japan, and Singapore. Int. J. Equity Health. 2023;22:224. doi: 10.1186/s12939-023-02034-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-023-02034-x</ArticleId><ArticleId IdType="pmc">PMC10588018</ArticleId><ArticleId IdType="pubmed">37864164</ArticleId></ArticleIdList></Reference><Reference><Citation>Desclaux A., Sow K., Sams K. Uncertainties beyond preparedness: COVID-19 vaccination in Senegal. J. Biosoc. Sci. 2024:1–21. doi: 10.1017/S0021932024000075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0021932024000075</ArticleId><ArticleId IdType="pubmed">38572543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sequeira A.R.S., Estrela M., DeWit K. COVID-19 Government policies in Portugal and Brazil: A three-year retrospective analysis. Health Policy Technol. 2024;13:100809. doi: 10.1016/j.hlpt.2023.100809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2023.100809</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie W., Shi L., Liu M., Yang J., Ma M., Sun G. Disparities and effectiveness of COVID-19 vaccine policies in three representative European countries. Int. J. Equity Health. 2024;23:16. doi: 10.1186/s12939-024-02110-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-024-02110-w</ArticleId><ArticleId IdType="pmc">PMC10825987</ArticleId><ArticleId IdType="pubmed">38287322</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron-Blake E., Tatlow H., Andretti B., Boby T., Green K., Hale T., Petherick A., Phillips T., Pott A., Wade A., et al. A panel dataset of COVID-19 vaccination policies in 185 countries. Nat. Hum. Behav. 2023;7:1402–1413. doi: 10.1038/s41562-023-01615-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-023-01615-8</ArticleId><ArticleId IdType="pmc">PMC10444623</ArticleId><ArticleId IdType="pubmed">37414885</ArticleId></ArticleIdList></Reference><Reference><Citation>Pushkaran A., Chattu V.K., Narayanan P. A critical analysis of COVAX alliance and corresponding global health governance and policy issues: A scoping review. BMJ Glob. Health. 2023;8:1–10. doi: 10.1136/bmjgh-2023-012168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-012168</ArticleId><ArticleId IdType="pmc">PMC10551961</ArticleId><ArticleId IdType="pubmed">37793808</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan T., Beardsley J., Marais B.J., Nguyen T.A., Fox G.J. The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines. Vaccines. 2021;9:326. doi: 10.3390/vaccines9040326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9040326</ArticleId><ArticleId IdType="pmc">PMC8066252</ArticleId><ArticleId IdType="pubmed">33915829</ArticleId></ArticleIdList></Reference><Reference><Citation>Wouters O.J., Shadlen K.C., Salcher-Konrad M., Pollard A.J., Larson H.J., Teerawattananon Y., Jit M. Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. Lancet. 2021;397:1023–1034. doi: 10.1016/S0140-6736(21)00306-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00306-8</ArticleId><ArticleId IdType="pmc">PMC7906643</ArticleId><ArticleId IdType="pubmed">33587887</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabia S., Wonodi C.B., Vilajeliu A., Sussman S., Olson K., Cooke R., Udayakumar K., Twose C., Ezeanya N., Adefarrell A.A., et al. Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review. Vaccines. 2023;11:974. doi: 10.3390/vaccines11050974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11050974</ArticleId><ArticleId IdType="pmc">PMC10222130</ArticleId><ArticleId IdType="pubmed">37243078</ArticleId></ArticleIdList></Reference><Reference><Citation>Md Khairi L.N.H., Fahrni M.L., Lazzarino A.I. The Race for Global Equitable Access to COVID-19 Vaccines. Vaccines. 2022;10:1306. doi: 10.3390/vaccines10081306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10081306</ArticleId><ArticleId IdType="pmc">PMC9412387</ArticleId><ArticleId IdType="pubmed">36016194</ArticleId></ArticleIdList></Reference><Reference><Citation>Privor-Dumm L., Excler J.-L., Gilbert S., Abdool Karim S.S., Hotez P.J., Thompson D., Kim J.H. Vaccine access, equity and justice: COVID-19 vaccines and vaccination. BMJ Glob. Health. 2023;8:e011881. doi: 10.1136/bmjgh-2023-011881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-011881</ArticleId><ArticleId IdType="pmc">PMC10254992</ArticleId><ArticleId IdType="pubmed">37290896</ArticleId></ArticleIdList></Reference><Reference><Citation>Manriquez Roa T., Holzer F., Luna F., Biller-Andorno N. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines. Int. J. Public Health. 2021;66:1604236. doi: 10.3389/ijph.2021.1604236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ijph.2021.1604236</ArticleId><ArticleId IdType="pmc">PMC8758559</ArticleId><ArticleId IdType="pubmed">35035347</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting of the Strategic Advisory Group of Experts on Immunization, 22–24 March 2021: Conclusions and Recommendations.  [(accessed on 30 April 2024)].  Available online:  https://www.who.int/publications-detail-redirect/meeting-of-the-strategic-advisory-group-of-experts-on-immunization-22-24-march-2021-conclusions-and-recommendations.</Citation></Reference><Reference><Citation>Guidance on Operational Microplanning for COVID-19 Vaccination.  [(accessed on 18 July 2024)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccination-microplanning-2023.1.</Citation></Reference><Reference><Citation>Hasan Q., Elfakki E., Fahmy K., Mere O., Ghoniem A., Langar H., Musa N., Attia R., Othman M.M., Samhouri D., et al. Inequities in the deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region, 2020–2021. BMJ Glob. Health. 2022;7:e008139. doi: 10.1136/bmjgh-2021-008139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-008139</ArticleId><ArticleId IdType="pmc">PMC9315235</ArticleId><ArticleId IdType="pubmed">35764354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayenigbara I.O., Adegboro J.S., Ayenigbara G.O., Rowland O., Olofintuyi O.O. The challenges to a successful COVID-19 vaccination programme in Africa. Germs. 2021;11:427–440. doi: 10.18683/germs.2021.1280.</Citation><ArticleIdList><ArticleId IdType="doi">10.18683/germs.2021.1280</ArticleId><ArticleId IdType="pmc">PMC8548036</ArticleId><ArticleId IdType="pubmed">34722365</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogler S., Haasis M.A., van den Ham R., Humbert T., Garner S., Suleman F. European collaborations on medicine and vaccine procurement. Bull. World Health Organ. 2021;99:715–721. doi: 10.2471/BLT.21.285761.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.21.285761</ArticleId><ArticleId IdType="pmc">PMC8477421</ArticleId><ArticleId IdType="pubmed">34621089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ares-Blanco S., Astier-Peña M.P., Gómez-Bravo R., Fernández-García M., Bueno-Ortiz J.M. Human resource management and vaccination strategies in primary care in Europe during COVID-19 pandemic. Atención Primaria. 2021;53:102132. doi: 10.1016/j.aprim.2021.102132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aprim.2021.102132</ArticleId><ArticleId IdType="pmc">PMC8188304</ArticleId><ArticleId IdType="pubmed">34256236</ArticleId></ArticleIdList></Reference><Reference><Citation>Masresha B., Ruiz M.A.S., Atuhebwe P., Mihigo R. The first year of COVID-19 vaccine roll-out in Africa: Challenges and lessons learned. Pan Afr. Med. J. 2022;41:2. doi: 10.11604/pamj.supp.2022.41.2.33686.</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.supp.2022.41.2.33686</ArticleId><ArticleId IdType="pmc">PMC9474932</ArticleId><ArticleId IdType="pubmed">36159028</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel R., Forman R., Milstein R., Mastylak A., Czabanowska K., Czypionka T., Durand-Zaleski I., Hirche A., Krysinska-Pisarek M., Maynou L., et al. Divergent COVID-19 vaccine policies: Policy mapping of ten European countries. Vaccine. 2023;41:2804–2810. doi: 10.1016/j.vaccine.2023.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.03.036</ArticleId><ArticleId IdType="pmc">PMC10030332</ArticleId><ArticleId IdType="pubmed">36967287</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadeddu C., Rosano A., Villani L., Coiante G.B., Minicucci I., Pascucci D., de Waure C. Planning and Organization of the COVID-19 Vaccination Campaign: An Overview of Eight European Countries. Vaccines. 2022;10:1631. doi: 10.3390/vaccines10101631.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101631</ArticleId><ArticleId IdType="pmc">PMC9609247</ArticleId><ArticleId IdType="pubmed">36298496</ArticleId></ArticleIdList></Reference><Reference><Citation>World Bank Country and Lending Groups—World Bank Data Help Desk.  [(accessed on 25 June 2024)].  Available online:  https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.</Citation></Reference><Reference><Citation>COVID-19 Vaccines Technical Documents.  [(accessed on 24 July 2024)].  Available online:  https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization/covid-19-materials.</Citation></Reference><Reference><Citation>Rashedi R., Samieefar N., Masoumi N., Mohseni S., Rezaei N. COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts. J. Med. Virol. 2022;94:1294–1299. doi: 10.1002/jmv.27463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27463</ArticleId><ArticleId IdType="pmc">PMC8661746</ArticleId><ArticleId IdType="pubmed">34796525</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieger J.M. Analysis|Trump’s Administration Fell Far Short of Its Own Vaccine Promises. Washington Post. Jan 19, 2021.  [(accessed on 14 August 2024)].  Available online:  https://www.washingtonpost.com/politics/2021/01/19/trumps-administration-fell-far-short-its-own-vaccine-promises/</Citation></Reference><Reference><Citation>New Collaboration Makes Further 100 Million Doses of COVID-19 Vaccine Available to Low- and Middle-Income Countries.  [(accessed on 2 July 2024)].  Available online:  https://www.gavi.org/news/media-room/new-collaboration-makes-further-100-million-doses-covid-19-vaccine-available-low.</Citation></Reference><Reference><Citation>WHO SAGE Values Framework for the Allocation and Prioritization of COVID-19 Vaccination.  [(accessed on 18 July 2024)].  Available online:  https://www.who.int/publications/i/item/who-sage-values-framework-for-the-allocation-and-prioritization-of-covid-19-vaccination.</Citation></Reference><Reference><Citation>European Court of Auditors . EU COVID-19 Vaccine Procurement: Sufficient Doses Secured after Initial Challenges, but Performance of the Process Not Sufficiently Assessed. Publications Office; Luxembourg: 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.2865/569767</ArticleId></ArticleIdList></Reference><Reference><Citation>African Vaccine Acquisition Trust Delivers 12 000 Doses of COVID-19 Vaccine to the African Union|Union Africaine.  [(accessed on 21 July 2024)].  Available online:  https://au.int/fr/node/40771.</Citation></Reference><Reference><Citation>PAHO Revolving Fund—PAHO/WHO|Pan American Health Organization.  [(accessed on 21 July 2024)].  Available online:  https://www.paho.org/en/revolving-fund.</Citation></Reference><Reference><Citation>Zhou Y.R. Vaccine nationalism: Contested relationships between COVID-19 and globalization. Globalizations. 2022;19:450–465. doi: 10.1080/14747731.2021.1963202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14747731.2021.1963202</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Market Dashboard|UNICEF Supply Division.  [(accessed on 22 July 2024)].  Available online:  https://www.unicef.org/supply/covid-19-vaccine-market-dashboard.</Citation></Reference><Reference><Citation>Building-Confidence-in-Routine-Immunisation-Social-Media-Listening-and-Engagement-Toolkit.pdf.  [(accessed on 23 June 2024)].  Available online:  https://www.vaccineconfidence.org/wp-content/uploads/Building-confidence-in-routine-immunisation-Social-media-listening-and-engagement-toolkit.pdf.</Citation></Reference><Reference><Citation>World Health Organization  . Monitoring the Building Blocks of Health Systems: A Handbook of Indicators and Their Measurement Strategies. World Health Organization; Geneva, Switzerland: 2010.  [(accessed on 8 July 2023)].  Available online:  https://apps.who.int/iris/handle/10665/258734.</Citation></Reference><Reference><Citation>The Best Healthcare in the World: Country Rankings. International Citizens Insurance.  [(accessed on 8 August 2024)].  Available online:  https://www.internationalinsurance.com/health/systems/</Citation></Reference><Reference><Citation>Chen Z., Zheng W., Wu Q., Chen X., Peng C., Tian Y., Sun R., Dong J., Wang M., Zhou X., et al. Global diversity of policy, coverage, and demand of COVID-19 vaccines: A descriptive study. BMC Med. 2022;20:130. doi: 10.1186/s12916-022-02333-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02333-0</ArticleId><ArticleId IdType="pmc">PMC8977121</ArticleId><ArticleId IdType="pubmed">35369871</ArticleId></ArticleIdList></Reference><Reference><Citation>Boschiero N. COVID-19 Vaccines as Global Common Goods: An Integrated Approach of Ethical, Economic Policy and Intellectual Property Management. Glob. Jurist. 2022;22:177–230. doi: 10.1515/gj-2021-0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/gj-2021-0042</ArticleId></ArticleIdList></Reference><Reference><Citation>Behind the COVID-19 Vaccine Approval Process.  [(accessed on 29 July 2024)].  Available online:  https://www.hackensackmeridianhealth.org/en/healthu/2020/12/09/behind-the-covid-19-vaccine-approval-process.</Citation></Reference><Reference><Citation>Glied S. Strategy drives implementation: COVID vaccination in Israel. Isr. J. Health Policy Res. 2021;10:9. doi: 10.1186/s13584-021-00445-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13584-021-00445-1</ArticleId><ArticleId IdType="pmc">PMC7848666</ArticleId><ArticleId IdType="pubmed">33522945</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Population (2024)—Worldometer.  [(accessed on 24 July 2024)].  Available online:  https://www.worldometers.info/world-population/us-population/</Citation></Reference><Reference><Citation>Why Is Singapore Leading in Asia’s COVID-19 Vaccine Effort? Yahoo Finance.  [(accessed on 23 July 2024)].  Available online:  https://sg.finance.yahoo.com/news/why-singapore-leading-asias-covid-132839717.html.</Citation></Reference><Reference><Citation>Dorji T., Tamang S.T. Bhutan’s experience with COVID-19 vaccination in 2021. BMJ Glob. Health. 2021;6:e005977. doi: 10.1136/bmjgh-2021-005977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005977</ArticleId><ArticleId IdType="pmc">PMC8136800</ArticleId><ArticleId IdType="pubmed">34006520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim W.H., Wong W.M. COVID-19: Notes from the Front Line, Singapore’s Primary Health Care Perspective. Ann. Fam. Med. 2020;18:259–261. doi: 10.1370/afm.2539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.2539</ArticleId><ArticleId IdType="pmc">PMC7214001</ArticleId><ArticleId IdType="pubmed">32393562</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Vaccine: Swiss Federal Government Signs Another Contract with Pfizer.  [(accessed on 7 August 2024)].  Available online:  https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-82627.html.</Citation></Reference><Reference><Citation>The Secrets to Israel’s Coronavirus Vaccination Success. POLITICO.  [(accessed on 20 July 2024)].  Available online:  https://www.politico.eu/article/israel-coronavirus-vaccine-success-secret/</Citation></Reference><Reference><Citation>COVAX Announces Additional Deals to Access Promising COVID-19 Vaccine Candidates; Plans Global Rollout Starting Q1 2021.  [(accessed on 7 August 2024)].  Available online:  https://www.who.int/news/item/18-12-2020-covax-announces-additional-deals-to-access-promising-covid-19-vaccine-candidates-plans-global-rollout-starting-q1-2021.</Citation></Reference><Reference><Citation>Callaway E. The unequal scramble for coronavirus vaccines—By the numbers. Nature. 2020;584:506–507. doi: 10.1038/d41586-020-02450-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02450-x</ArticleId><ArticleId IdType="pubmed">32839593</ArticleId></ArticleIdList></Reference><Reference><Citation>Latin American Countries Have Accused Pfizer of ‘High-Level Bullying’ during COVID-19 Vaccine Negotiations, According to a Report by the Bureau of Investigative Journalism Published in Partnership with STAT.  [(accessed on 20 July 2024)].  Available online:  https://www.pharmaceutical-technology.com/company-news/pfizer-latin-american-vaccine/?cf-view.</Citation></Reference><Reference><Citation>Phillips T. “We’re Being Left Behind”: Anger and Confusion in Brazil as Vaccine Program Lags. The Guardian. Dec 31, 2020.  [(accessed on 20 July 2024)].  Available online:  https://www.theguardian.com/world/2020/dec/31/brazil-coronavirus-vaccine-jair-bolsonaro.</Citation></Reference><Reference><Citation>Bolosonaro Says COVID Vaccine May Turn People into Crocodiles in Bizarre Rant. The Independent. 2020.  [(accessed on 20 July 2024)].  Available online:  https://www.independent.co.uk/news/world/politics/bolosonaro-covid-vaccine-brazil-crocodiles-b1776753.html.</Citation></Reference><Reference><Citation>Weintraub R.L., Subramanian L., Karlage A., Ahmad I., Rosenberg J. COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now. Health Aff. 2021;40:33–41. doi: 10.1377/hlthaff.2020.01523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2020.01523</ArticleId><ArticleId IdType="pubmed">33211554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawes-Wickwar S., Ghio D., Tang M.Y., Keyworth C., Stanescu S., Westbrook J., Jenkinson E., Kassianos A.P., Scanlan D., Garnett N., et al. A Rapid Systematic Review of Public Responses to Health Messages Encouraging Vaccination against Infectious Diseases in a Pandemic or Epidemic. Vaccines. 2021;9:72. doi: 10.3390/vaccines9020072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9020072</ArticleId><ArticleId IdType="pmc">PMC7909419</ArticleId><ArticleId IdType="pubmed">33498395</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunization Agenda 2030.  [(accessed on 3 April 2024)].  Available online:  https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030.</Citation></Reference><Reference><Citation>World Health Assembly Agreement Reached on Wide-Ranging, Decisive Package of Amendments to Improve the International Health Regulations.  [(accessed on 14 August 2024)].  Available online:  https://www.who.int/news/item/01-06-2024-world-health-assembly-agreement-reached-on-wide-ranging--decisive-package-of-amendments-to-improve-the-international-health-regulations--and-sets-date-for-finalizing-negotiations-on-a-proposed-pandemic-agreement.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>